Additionally, both in vitro and in vivo studies have shown that LINC01123 accelerates malignancy in NSCLC by acting as a ceRNA, thereby influencing multiple axes including miR-4766-5p/PYCR1 (30), miR-199a-5p/c-Myc (28), and miR-449b-5p/NOTCH1 (40). Here, MYC is linked to non-small cell lung carcinoma.